Biologic treatments for shoulder pain

Abstract

Shoulder pain is a common musculoskeletal complaint that can result from a variety of pathologic processes, including arthritis, bursitis and rotator cuff disease. Physicians often initiate treatment of shoulder pain with oral medications and progress to injectable medications for patients with more severe pain. Several promising new therapies for shoulder pain have emerged in recent years. These treatment modalities, which include cytokines, growth factors, platelet rich plasma, and stem cells, could provide physicians with powerful medications to treat patients with severe shoulder pain. This article provides a review of the biologic treatments available to physicians treating patients with shoulder pain and highlights some of the research and newest developments in the use of cytokines, growth factors, platelet rich plasma and stem cells for shoulder pathology.

A multi-center, double-blind, randomized, placebo-controlled trial protocol to assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome: the TRAumeel in ROtator cuff syndrome (TRARO) study protocol

“…The majority of these conditions can be managed with conservative treatment [ 2 , 4 ], and conservative therapy can include a number of novel treatments [ 5 ]. Rotator cuff dysfunction is a particularly important entity because it occurs frequently, and indicative with complete tear, may necessitate surgical treatment [ 2 , 6 , 7 ].…”